Friday - February 06, 2026

Category Archives: Business

Triple Negative Breast Cancer Market is expected to grow at a CAGR of 4.70% by 2034, estimates DelveInsight

Triple Negative Breast Cancer companies working in the market are Johnson & Johnson Private Limited, Cipla Inc, Abbott, AbbVie Inc, Merck KGaA, Sun Pharmaceutical, Aurobindo Pharma, Lupin, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Pfizer Inc, Mylan N.V., Novartis AG, Bristol-Myers … Continue reading →

Non-Alcoholic Fatty Liver Disease Treatment Pipeline Shows Strong Momentum as 90+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2025” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the Non Alcoholic Fatty Liver Disease pipeline drug profiles, including clinical and … Continue reading →

Marginal Zone Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Marginal Zone Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Diabetes Clinical Trial Pipeline Expands as 200+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Diabetes Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Diabetes pipeline landscape. It covers the Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetes therapeutics … Continue reading →

Cervical Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 70+ Key Companies | DelveInsight

DelveInsight’s, “Cervical Cancer Pipeline Insight 2025” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Cervical Cancer pipeline landscape. It covers the Cervical Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

CAR-T Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “CAR T-Cell Therapy Pipeline Insight 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the CAR T-Cell Therapy pipeline landscape. It covers the CAR T-Cell Therapy Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Pulmonary Arterial Hypertension Pipeline Outlook: 55+ Companies Advancing Next-Generation Treatment Options, analyses DelveInsight

Pulmonary Arterial Hypertension Pipeline Pulmonary Arterial Hypertension Companies include Aerovate Therapeutics, Novartis, Keros Therapeutics, Vigonvita Life Sciences, Insmed Incorporated, Chugai Pharmaceutical, Merck & Co., Janssen Pharmaceuticals, Actelion, Gossamer Bio, Lung Biotechnology PBC, United Therapeutics, Gilead Sciences, Acceleron Pharma, Eiger BioPharmaceuticals, … Continue reading →

Crohn’s Disease market size was expected to grow at a significant CAGR of 4.3% by 2034, estimates DelveInsight

Crohn’s Disease market Crohn’s Disease companies are Takeda Pharmaceutical, Janssen Pharmaceuticals, UCB, Biogen, AbbVie, AstraZeneca, Tillotts Pharma (Zeria Pharmaceutical), Gilead Sciences and Galapagos NV, Boehringer Ingelheim, Celgene (Bristol Myers Squibb), Eli Lilly and Company, RedHill Biopharma, Arena Pharmaceuticals, Mesoblast, and … Continue reading →

Chronic Periodontitis Pipeline Analysis: 10+ Companies Racing to Deliver Next-Generation Oral Health Therapies, analyses DelveInsight

Chronic Periodontitis Pipeline Chronic Periodontitis companies include Amyndas Pharmaceuticals, Takeda, CSL Behring, Vaxcyte, Noveome, Perioc, and others. DelveInsight’s report, “Chronic Periodontitis Pipeline Insight” delivers detailed analysis of more than 10 companies and over 10 investigational therapies within the Chronic Periodontitis … Continue reading →